Jeffrey G. Suico

1.6k total citations · 1 hit paper
24 papers, 812 citations indexed

About

Jeffrey G. Suico is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Jeffrey G. Suico has authored 24 papers receiving a total of 812 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Surgery. Recurrent topics in Jeffrey G. Suico's work include Drug Transport and Resistance Mechanisms (6 papers), Lipoproteins and Cardiovascular Health (4 papers) and Diabetes Management and Research (4 papers). Jeffrey G. Suico is often cited by papers focused on Drug Transport and Resistance Mechanisms (6 papers), Lipoproteins and Cardiovascular Health (4 papers) and Diabetes Management and Research (4 papers). Jeffrey G. Suico collaborates with scholars based in United States, United Kingdom and Australia. Jeffrey G. Suico's co-authors include Clement J. McDonald, Raymond D. Aller, Gilbert Hill, James T. Case, Arden W. Forrey, J. N. Hook, Stanley M. Huff, J. Marc Overhage, Giacomo Ruotolo and Stephen J. Nicholls and has published in prestigious journals such as JAMA, The Journal of Clinical Endocrinology & Metabolism and Diabetes.

In The Last Decade

Jeffrey G. Suico

24 papers receiving 784 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Muvalaplin, an Oral Small Molecule Inhibitor of Lipoprotein(a) Formation

2023 112 citations Stephen J. Nicholls, Steven E. Nissen et al. JAMA profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jeffrey G. Suico United States	12	301	199	172	170	119	24	812
Frank DeFalco United States	12	230 0.8×	161 0.8×	127 0.7×	144 0.8×	339 2.8×	24	934
Salim Janmohamed United Kingdom	9	121 0.4×	87 0.4×	118 0.7×	93 0.5×	135 1.1×	13	684
Stephen B. Ellis United States	13	192 0.6×	144 0.7×	127 0.7×	199 1.2×	41 0.3×	25	973
Aozi Feng China	14	170 0.6×	203 1.0×	55 0.3×	138 0.8×	66 0.6×	34	1.2k
Omri Gottesman United States	19	519 1.7×	122 0.6×	204 1.2×	302 1.8×	121 1.0×	23	1.6k
Ronald Tamler United States	16	191 0.6×	123 0.6×	65 0.4×	90 0.5×	389 3.3×	34	995
Daniel J. Nigrin United States	15	117 0.4×	95 0.5×	212 1.2×	114 0.7×	83 0.7×	22	797
Jason H. Karnes United States	18	304 1.0×	119 0.6×	61 0.4×	93 0.5×	98 0.8×	62	1.3k
Fabrizio Consorti Italy	16	238 0.8×	230 1.2×	62 0.4×	123 0.7×	216 1.8×	72	941
Anushi Shah United States	12	431 1.4×	58 0.3×	77 0.4×	155 0.9×	34 0.3×	26	793

Countries citing papers authored by Jeffrey G. Suico

Since Specialization

Citations

This map shows the geographic impact of Jeffrey G. Suico's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey G. Suico with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey G. Suico more than expected).

Fields of papers citing papers by Jeffrey G. Suico

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey G. Suico. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey G. Suico. The network helps show where Jeffrey G. Suico may publish in the future.

Co-authorship network of co-authors of Jeffrey G. Suico

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey G. Suico. A scholar is included among the top collaborators of Jeffrey G. Suico based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey G. Suico. Jeffrey G. Suico is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Broad, Lisa M., Jeffrey G. Suico, P. Kellie Turner, et al.. (2025). Preclinical and clinical evaluation of a novel TRPA1 antagonist LY3526318. Pain. 166(8). 1893–1908. 3 indexed citations

Nicholls, Stephen J., Steven E. Nissen, Cynthia Griggs Fleming, et al.. (2023). Muvalaplin, an Oral Small Molecule Inhibitor of Lipoprotein(a) Formation. JAMA. 330(11). 1042–1042. 112 indexed citations breakdown →

Miller, Jennifer L., André Lacroix, Lynne M. Bird, et al.. (2022). The Efficacy, Safety, and Pharmacology of a Ghrelin O-Acyltransferase Inhibitor for the Treatment of Prader-Willi Syndrome. The Journal of Clinical Endocrinology & Metabolism. 107(6). e2373–e2380. 13 indexed citations

Suico, Jeffrey G., Ulrike Hövelmann, Shuyu Zhang, et al.. (2020). Glucagon Administration by Nasal and Intramuscular Routes in Adults With Type 1 Diabetes During Insulin-Induced Hypoglycaemia: A Randomised, Open-Label, Crossover Study. Diabetes Therapy. 11(7). 1591–1603. 19 indexed citations

Spaepen, Erik, et al.. (2020). Nasal Glucagon Delivery is More Successful than Injectable Delivery: A Simulated Severe Hypoglycemia Rescue. Endocrine Practice. 26(4). 407–415. 19 indexed citations

Child, Christopher J., et al.. (2019). 13-LB: Nasal vs. Injected Glucagon: User Experience Results of a Simulated Severe Hypoglycemia Study. Diabetes. 68(Supplement_1). 3 indexed citations

Suico, Jeffrey G., Ulrike Hövelmann, Shuyu Zhang, et al.. (2018). Nasal Glucagon: Potentially Viable Alternative to Treat Insulin-Induced Hypoglycemia in Adults with Type 1 Diabetes. Canadian Journal of Diabetes. 42(5). S53–S53. 1 indexed citations

Yuen, Eunice, et al.. (2018). Evaluation of the effects of an oral notch inhibitor, crenigacestat (LY3039478), on QT interval, and bioavailability studies conducted in healthy subjects. Cancer Chemotherapy and Pharmacology. 83(3). 483–492. 7 indexed citations

Leohr, Jennifer, Debra Luffer‐Atlas, Mengdie Luo, et al.. (2017). Serum Lipid and Protein Changes in Healthy Dyslipidemic Subjects Given a Selective Inhibitor of p70 S6 Kinase‐1. The Journal of Clinical Pharmacology. 58(4). 412–424. 2 indexed citations

10.

Small, David S., et al.. (2016). Impact of Increased Gastric pH on the Pharmacokinetics of Evacetrapib in Healthy Subjects. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 36(7). 749–756. 4 indexed citations

11.

Small, David S., et al.. (2016). Effect of hepatic or renal impairment on the pharmacokinetics of evacetrapib. European Journal of Clinical Pharmacology. 72(5). 563–572. 1 indexed citations

12.

Small, David S., Wei Zhang, Jane Royalty, et al.. (2015). A Multidose Study to Examine the Effect of Food on Evacetrapib Exposure at Steady State. Journal of Cardiovascular Pharmacology and Therapeutics. 20(5). 483–489. 8 indexed citations

13.

Cannady, Ellen A., Stuart Friedrich, Jessica Rehmel, et al.. (2015). Evacetrapib: in vitro and clinical disposition, metabolism, excretion, and assessment of drug interaction potential with strong CYP3A and CYP2C8 inhibitors. Pharmacology Research & Perspectives. 3(5). e00179–e00179. 6 indexed citations

14.

Cannady, Ellen A., Jeffrey G. Suico, Stuart Friedrich, et al.. (2015). CYP‐mediated drug–drug interactions with evacetrapib, an investigational CETP inhibitor: in vitro prediction and clinical outcome. British Journal of Clinical Pharmacology. 80(6). 1388–1398. 8 indexed citations

15.

Suico, Jeffrey G., Stuart Friedrich, Ellen A. Cannady, et al.. (2014). Effects of the cholesteryl ester transfer protein inhibitor evacetrapib on lipoproteins, apolipoproteins and 24-h ambulatory blood pressure in healthy adults. Journal of Pharmacy and Pharmacology. 66(11). 1576–1585. 31 indexed citations

16.

McDonald, Clement J., Stanley M. Huff, Jeffrey G. Suico, et al.. (2003). LOINC, a Universal Standard for Identifying Laboratory Observations: A 5-Year Update. Clinical Chemistry. 49(4). 624–633. 370 indexed citations

17.

Overhage, J. Marc, Jeffrey G. Suico, & Clement J. McDonald. (2001). Electronic Laboratory Reporting: Barriers, Solutions and Findings. Journal of Public Health Management and Practice. 7(6). 60–66. 63 indexed citations

18.

Schadow, Gunther, et al.. (1999). Units of Measure in Clinical Information Systems. Journal of the American Medical Informatics Association. 6(2). 151–162. 35 indexed citations

19.

McDonald, Clement J., et al.. (1998). What is done, what is needed and what is realistic to expect from medical informatics standards. International Journal of Medical Informatics. 48(1-3). 5–12. 30 indexed citations

20.

Suico, Jeffrey G., Deanna J. Marriott, Frank Vinicor, & Debra K. Litzelman. (1998). Behaviors predicting foot lesions in patients with non-insulin-dependent diabetes mellitus. Journal of General Internal Medicine. 13(7). 482–484. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact